Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults (source: Medical News Today)
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demons… (source: Medical News Today) – RSS news feeds and Widgets on Feedzilla.com
More From Stop Anxiety
- Naltrexone Nixed For Substance Abuse In Patients With Schizophrenia (source: Medical News Today)
- Mind Calls For Regulation Of Counsellors And Psychotherapists, UK (source: Medical News Today)
- Illinois State Senator Cullerton Recognized For Advocacy Work On Mental Health Issues (source: Medical News Today)
- Rhode Island Congressman Patrick Kennedy Recognized For Advocacy Work On Mental Health Issues (source: Medical News Today)
- The Pentagon Tragedy: Mental Illness, Violence And What Reporters Should Ask (source: Medical News Today)

















